In vitro binding study for sevelamer carbonate for Europe submission [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2023-02-28 18:15 (412 d 18:13 ago) – Posting: # 23481
Views: 1,698

Dear Jansari!

❝ we were already given justification based on this sentence.and explain that our study is passing within T/R ratio as per acceptance limit 0.9 to 1.1...but they are not accepting the same and again raised the queries....so now we are repeating the same study ,.


So you are aware about the acceptance limit. Currently what I am able to understand is that you are referring term regulatory for your company's regulatory team and not the authority's team. If it's authority's team- you are already having your answers.

❝ can I have your mail ID ?so I can detailed out the study detail which results we obtained in the study..and what exactly regulatory asked?


You can contact me via contact form in users section but your mail is is not registered, so i am not able to contact you through same medium.
[image]

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,649 registered users;
40 visitors (0 registered, 40 guests [including 7 identified bots]).
Forum time: 13:28 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5